28
Participants
Start Date
May 31, 2012
Primary Completion Date
August 31, 2015
Study Completion Date
June 1, 2017
temozolomide
standard of care drug
3'-deoxy-3'-[18F]fluorothymidine
tracer used for FLT PET CT
pharmacological study
Mibefradil
Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh
Johns Hopkins University, Baltimore
Winship Cancer Institute of Emory University, Atlanta
Henry Ford Hospital, Detroit
UAB Comprehensive Cancer Center, Birmingham
Wake Forest University Comprehensive Cancer Center, Winston-Salem
Abramson Cancer Center of the University of Pennsylvania, Philadelphia
National Cancer Institute (NCI)
NIH
Cavion, Inc.
INDUSTRY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER